| http://purl.uniprot.org/citations/32325912 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/32325912 | http://www.w3.org/2000/01/rdf-schema#comment | "Ghrelin, a 28-amino acid peptide, is a strong growth hormone secretagogue and a regulator of food intake. In addition, ghrelin is thought to play a role in insulin secretion and in glucose homeostasis. A lot of contradictory data have been reported in the literature regarding the co-localization of ghrelin with other hormones in the islet of Langerhans, its role in insulin secretion and attenuation of type 2 diabetes mellitus. In this study, we investigate the effect of chronic ghrelin treatment on glucose, body weight and insulin level in normal and streptozotocin-induced diabetic male Wistar rats. We have also examined the distribution pattern and co-localization of ghrelin with insulin in pancreatic islet cells using immunohistochemistry and immune-electron microscopy and the ability of ghrelin to stimulate insulin release from the CRL11065 beta cell line. Control, non-diabetic groups received intraperitoneal injection of normal saline, while treated groups received intraperitoneal injection of 5 µg/kg body weight of ghrelin (amino acid chain 24-51) on a daily basis for a duration of four weeks. Our results show that the administration of ghrelin increases the number of insulin-secreting beta cells and serum insulin level in both normal and diabetic rats. We also demonstrated that ghrelin co-localizes with insulin in pancreatic islet cells and that the pattern of ghrelin distribution is altered after the onset of diabetes. Moreover, ghrelin at a dose of 10-6M and 10-12M increased insulin release from the CRL11065 beta cell line. In summary, ghrelin co-localizes with insulin in the secretory granules of pancreatic beta cells and enhances insulin production."xsd:string |
| http://purl.uniprot.org/citations/32325912 | http://purl.org/dc/terms/identifier | "doi:10.3390/biom10040633"xsd:string |
| http://purl.uniprot.org/citations/32325912 | http://purl.uniprot.org/core/author | "D'Souza C."xsd:string |
| http://purl.uniprot.org/citations/32325912 | http://purl.uniprot.org/core/author | "Hameed R."xsd:string |
| http://purl.uniprot.org/citations/32325912 | http://purl.uniprot.org/core/author | "Mohsin S."xsd:string |
| http://purl.uniprot.org/citations/32325912 | http://purl.uniprot.org/core/author | "Adeghate E.A."xsd:string |
| http://purl.uniprot.org/citations/32325912 | http://purl.uniprot.org/core/author | "Elabadlah H."xsd:string |
| http://purl.uniprot.org/citations/32325912 | http://purl.uniprot.org/core/date | "2020"xsd:gYear |
| http://purl.uniprot.org/citations/32325912 | http://purl.uniprot.org/core/name | "Biomolecules"xsd:string |
| http://purl.uniprot.org/citations/32325912 | http://purl.uniprot.org/core/pages | "E633"xsd:string |
| http://purl.uniprot.org/citations/32325912 | http://purl.uniprot.org/core/title | "Exogenous Ghrelin Increases Plasma Insulin Level in Diabetic Rats."xsd:string |
| http://purl.uniprot.org/citations/32325912 | http://purl.uniprot.org/core/volume | "10"xsd:string |
| http://purl.uniprot.org/citations/32325912 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/32325912 |
| http://purl.uniprot.org/citations/32325912 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/32325912 |
| http://purl.uniprot.org/uniprot/#_A6JHT2-mappedCitation-32325912 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/32325912 |
| http://purl.uniprot.org/uniprot/#_P01322-mappedCitation-32325912 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/32325912 |
| http://purl.uniprot.org/uniprot/A6JHT2 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/32325912 |
| http://purl.uniprot.org/uniprot/P01322 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/32325912 |